Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -22.45% is 40% below its 5-year average of -16.02%, near the low end of its 5-year range (-26.02%–-6.12%).
As of the fiscal period ended Tuesday, June 30, 2026. 6.90% above its 12-month average of -24.11%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -22.45%.
RETURN ON EQUITY (ROE)
-22.45%
RETURN ON EQUITY (ROE) AVG TTM
-24.11%
RETURN ON EQUITY (ROE) AVG 3Y
-19.71%
RETURN ON EQUITY (ROE) AVG 5Y
-16.02%
RETURN ON EQUITY (ROE) AVG 10Y
-36.54%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+6.90%
CURRENT VS 3Y AVG
-13.87%
CURRENT VS 5Y AVG
-40.08%
CURRENT VS 10Y AVG
+38.57%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
+46.57%
vs the sector median at left
MaxCyte, Inc.
Market Cap
$113.01M
Return on Equity (ROE)
-22.45%
TTM Avg
-24.11%
3Y Avg
-19.71%
5Y Avg
-16.02%
Market Cap
$114.34M
Return on Equity (ROE)
-209.73%
TTM Avg
-196.07%
3Y Avg
-130.72%
5Y Avg
-67.26%
Market Cap
$114.39M
Return on Equity (ROE)
-478.26%
TTM Avg
-687.50%
3Y Avg
165.05%
5Y Avg
111.70%
Market Cap
$113.56M
Return on Equity (ROE)
-105.40%
TTM Avg
-90.09%
3Y Avg
-60.23%
5Y Avg
-18.64%
Market Cap
$113.02M
Return on Equity (ROE)
N/A
TTM Avg
129.36%
3Y Avg
-24207.46%
5Y Avg
-16163.58%
Market Cap
$115.53M
Return on Equity (ROE)
-0.05%
TTM Avg
-43.47%
3Y Avg
9.13%
5Y Avg
-18.50%
Market Cap
$112.27M
Return on Equity (ROE)
-66.12%
TTM Avg
-291.11%
3Y Avg
1023.70%
5Y Avg
687.99%
Market Cap
$111.40M
Return on Equity (ROE)
N/A
TTM Avg
326.93%
3Y Avg
83.50%
5Y Avg
24.39%
Market Cap
$118.46M
Return on Equity (ROE)
-61.33%
TTM Avg
-137.84%
3Y Avg
-101.43%
5Y Avg
-77.25%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MaxCyte, Inc. (MXCT) | $113.01M | -22.45% | -24.11% | -19.71% | -16.02% |
| Genelux Corporation (GNLX)vs › | $114.34M | -209.73% | -196.07% | -130.72% | -67.26% |
| Lucid Diagnostics Inc. (LUCD)vs › | $114.39M | -478.26% | -687.50% | 165.05% | 111.70% |
| Caribou Biosciences, Inc. (CRBU)vs › | $113.56M | -105.40% | -90.09% | -60.23% | -18.64% |
| Foghorn Therapeutics Inc. (FHTX)vs › | $113.02M | N/A | 129.36% | -24207.46% | -16163.58% |
| Coya Therapeutics, Inc. (COYA)vs › | $115.53M | -0.05% | -43.47% | 9.13% | -18.50% |
| Unicycive Therapeutics, Inc. (UNCY)vs › | $112.27M | -66.12% | -291.11% | 1023.70% | 687.99% |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $111.40M | N/A | 326.93% | 83.50% | 24.39% |
| Spruce Biosciences, Inc. (SPRB)vs › | $118.46M | -61.33% | -137.84% | -101.43% | -77.25% |
| BGM Group Ltd. (BGM)vs › | $118.37M | -5.10% | -4.24% | -6.16% | 0.09% |
ROE
-22.4%
ROA
-19.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -22.45% |
| 2026-03-31 | -23.30% |
| 2025-12-31 | -26.02% |
| 2025-09-30 | -25.31% |
| 2025-06-30 | -23.47% |
| 2025-03-31 | -20.96% |
| 2024-12-31 | -19.91% |
| 2024-09-30 | -16.75% |
| 2024-06-30 | -16.01% |
| 2024-03-31 | -16.15% |
| 2023-12-31 | -16.33% |
| 2023-09-30 | -16.05% |
| 2023-06-30 | -13.54% |
| 2023-03-31 | -12.26% |
| 2022-12-31 | -9.28% |
| 2022-09-30 | -9.29% |
| 2022-06-30 | -7.73% |
| 2022-03-31 | -6.12% |
| 2021-12-31 | -7.26% |
| 2021-09-30 | -6.38% |
| 2021-06-30 | -21.92% |
| 2021-03-31 | -19.51% |
| 2020-12-31 | -35.56% |
| 2020-06-30 | -25.50% |
| 2020-03-31 | -82.49% |
| 2019-12-31 | -94.80% |
| 2019-09-30 | -97.24% |
| 2019-06-30 | -84.31% |
| 2019-03-31 | -69.74% |
| 2018-12-31 | -72.21% |
| 2018-09-30 | -78.46% |
| 2018-06-30 | -67.76% |
| 2018-03-31 | -66.17% |
| 2017-12-31 | -50.61% |
| 2017-09-30 | -41.58% |
| 2017-06-30 | -25.72% |
| 2017-03-31 | -20.62% |
| 2016-12-31 | -75.75% |
| 2016-09-30 | -70.34% |
| 2016-06-30 | -46.70% |
| 2016-03-31 | -48.24% |
| 2015-06-30 | -42.28% |
